Full Text View
Tabular View
No Study Results Posted
Related Studies
Caelyx as Primary Treatment for Patients With Breast Cancer and a History of Heart Disease and/or Age Over 65 Years (CAPRICE)
This study is ongoing, but not recruiting participants.
Study NCT00563953   Information provided by SOLTI Breast Cancer Research Group

First Received on November 26, 2007.   Last Updated on August 9, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Cancer
Additional conditions recognized in this trial
Breast Neoplasms
Heart Diseases
More general conditions related to this trial
Breast Diseases
Cardiovascular Diseases
Neoplasms
Neoplasms by Site
Skin Diseases
Interventions listed in this trial
Liposomal pegylated doxorubicine
Additional drug interventions recognized in this trial
Doxorubicin
More general drug interventions related to this trial
Antibiotics, Antineoplastic
Antineoplastic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
SOLTI Breast Cancer Research Group
Schering-Plough


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services